Sorrento gets Brazilian ANVISA clearance to start Long COVID therapy trial
Sorrento Therapeutics has secured the Brazilian ANVISA authorisation to start a Phase IIa trial of COVI-MSC for treating long COVID.
United Kingdom Henry Ji Centric Services For Laboratory Equipment Synova Health Drug Processing Technology
Source: clinicaltrialsarena.com